Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine

Clinical trial NCT02546752 · COMPLETED

Trial details

NCT number: NCT02546752
Sponsor: Regenstrief Institute, Inc.
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Human Papilloma Virus Infection Type 11 Human Papilloma Virus Infection Type 16 Human Papilloma Virus Infection Type 18 Human Papilloma Virus Infection Type 6 Cervical Cancer

Start date: 2015-09-01
Primary completion: 2016-05-01
Enrollment: 1306

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.